 | ||
| Beat Wall Street to This Pot Stock Zacks Member, Did you miss my earlier email? I want to give you one more chance to ride the historic growth trajectory of legal marijuana from $9 billion in 2017 . . . to an expected $32 billion by 2020 . . . to a possible $146 billion and more by 2025. Zacks' new approach avoids the dicey penny stocks, targeting the few growers, pharmaceuticals, financial firms, suppliers – both established and start-ups – that are the true innovators and offer the most reliable potential for double and triple-digit gains. Tuesday morning you can see a brand-new addition to our portfolio: This little-known biopharmaceutical company recently announced positive results on tests of a breakthrough new drug candidate that could add and estimated $500 million in revenue every year. This new drug could send profits skyrocketing. It couldn't be easier to gain 30-day access to the buys, sells, and commentary of our new Marijuana Innovators portfolio. Your total cost? Only $1. But please remember that we can't allow too many investors to jump on our selected stocks. The portfolio to entry again just hours from now – midnight tonight. Legalization of marijuana is fast becoming the Repeal of Alcohol Prohibition, the birth of the PC, the dawn of the Internet. Don't miss a generational investment opportunity like this. Good Investing,
| ||
 | ||
| This free resource is being sent by Zacks.com. We look for investment resources and inform you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer. Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research is not a licensed securities dealer, broker or US investment adviser or investment bank. The Zacks #1 Rank Performance covers the period beginning on January 1, 1988 through August 5, 2019. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank #1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed above. Zacks Emails Zacks Investment Research |
没有评论:
发表评论